CVS Health Corp (CVS) Holdings Reduced by Cypress Asset Management Inc. TX

Cypress Asset Management Inc. TX lowered its holdings in CVS Health Corp (NYSE:CVS) by 12.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,450 shares of the pharmacy operator’s stock after selling 3,220 shares during the quarter. Cypress Asset Management Inc. TX’s holdings in CVS Health were worth $1,907,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. raised its position in shares of CVS Health by 1.4% during the second quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock worth $6,159,825,000 after acquiring an additional 1,056,265 shares during the last quarter. FMR LLC raised its position in shares of CVS Health by 22.0% during the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after acquiring an additional 5,446,930 shares during the last quarter. Northern Trust Corp raised its position in shares of CVS Health by 5.5% during the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock worth $1,256,631,000 after acquiring an additional 807,639 shares during the last quarter. Nordea Investment Management AB raised its position in shares of CVS Health by 8.4% during the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after acquiring an additional 1,100,373 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of CVS Health by 4.8% during the third quarter. Bank of New York Mellon Corp now owns 10,579,307 shares of the pharmacy operator’s stock worth $860,309,000 after acquiring an additional 481,262 shares during the last quarter. 81.70% of the stock is currently owned by institutional investors.

CVS Health Corp (CVS) opened at $80.95 on Tuesday. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.00. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $80,897.54, a PE ratio of 16.73, a price-to-earnings-growth ratio of 1.26 and a beta of 0.90.

CVS Health (NYSE:CVS) last posted its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.64 earnings per share. equities research analysts predict that CVS Health Corp will post 5.89 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.47%. CVS Health’s dividend payout ratio is currently 41.32%.

A number of equities research analysts have recently weighed in on CVS shares. Robert W. Baird restated a “hold” rating and set a $77.00 target price on shares of CVS Health in a research report on Friday, October 27th. Needham & Company LLC upgraded CVS Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $69.02 to $79.00 in a research report on Friday, November 10th. Deutsche Bank restated a “hold” rating on shares of CVS Health in a research report on Tuesday, December 5th. Mizuho set a $90.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Finally, Raymond James Financial reiterated a “buy” rating on shares of CVS Health in a report on Monday, December 4th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. CVS Health presently has a consensus rating of “Buy” and an average price target of $87.25.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at $1,166,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.61% of the stock is owned by corporate insiders.

WARNING: This report was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.themarketsdaily.com/2018/01/23/cvs-health-corp-cvs-holdings-reduced-by-cypress-asset-management-inc-tx.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply